Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mutant dynactin in motor neuron disease.

Imke Puls1, Catherine Jonnakuty, Bernadette H LaMonte

  • 1Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892, USA. pulsi@ninds.nih.gov

Nature Genetics
|March 11, 2003
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Author Correction: Mitochondrial adaptor TRAK2 activates and functionally links opposing kinesin and dynein motors.

Nature communications·2026
Same author

PINK1/Parkin-dependent mitophagy mediates astrocytic inflammatory responses to mitochondrial damage.

bioRxiv : the preprint server for biology·2026
Same author

Knockout of the LRRK2-counteracting RAB phosphatase PPM1H disrupts axonal autophagy and exacerbates alpha-synuclein aggregation.

Cell reports·2026
Same author

Non-muscle tropomyosins inhibit myosin-19 and dynamically localize to mitochondrially associated actin filaments.

The Journal of biological chemistry·2026
Same author

Pathogenic KIF1A variants differentially disrupt axonal trafficking and impede synaptic development.

bioRxiv : the preprint server for biology·2026
Same author

Major Depressive Disorder and Serum Inflammatory Biomarkers as Predictors of Reward-Processing Dysfunction in an American Indian Sample.

Biological psychiatry. Cognitive neuroscience and neuroimaging·2025

A genetic mutation in the dynactin gene causes lower motor neuron disease by impairing axonal transport. This study links dynactin dysfunction to neuronal degeneration in motor neuron disease.

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • Impaired axonal transport is a proposed mechanism for neuronal degeneration in motor neuron disease.
  • Dynactin is a protein complex crucial for axonal transport.

Purpose of the Study:

  • To investigate the genetic basis of a lower motor neuron disease.
  • To determine the role of dynactin in motor neuron disease pathogenesis.

Main Methods:

  • Genetic linkage analysis to identify the disease-associated chromosomal region.
  • Mutation analysis of the dynactin gene within the linked interval.
  • In vitro binding assays to assess the impact of mutations on dynactin-microtubule interactions.

Main Results:

Related Experiment Videos

  • A 4 Mb region at chromosome 2p13 was linked to lower motor neuron disease.
  • A specific mutation in the dynactin gene was identified, causing an amino acid substitution.
  • The mutation distorted the dynactin microtubule-binding domain, leading to reduced microtubule binding.

Conclusions:

  • Dynactin dysfunction, caused by specific mutations, can lead to human motor neuron disease.
  • This study highlights the critical role of dynactin-mediated axonal transport in motor neuron health.